JP2021512966A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021512966A5 JP2021512966A5 JP2020564972A JP2020564972A JP2021512966A5 JP 2021512966 A5 JP2021512966 A5 JP 2021512966A5 JP 2020564972 A JP2020564972 A JP 2020564972A JP 2020564972 A JP2020564972 A JP 2020564972A JP 2021512966 A5 JP2021512966 A5 JP 2021512966A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- cancer
- seq
- therapy
- immunogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018900368A AU2018900368A0 (en) | 2018-02-07 | A vaccine composition and uses thereof | |
| AU2018900368 | 2018-02-07 | ||
| AU2018903518A AU2018903518A0 (en) | 2018-09-19 | A vaccine composition and uses thereof | |
| AU2018903518 | 2018-09-19 | ||
| AU2018903968A AU2018903968A0 (en) | 2018-10-19 | A vaccine composition and uses thereof | |
| AU2018903968 | 2018-10-19 | ||
| PCT/AU2019/050089 WO2019153042A1 (en) | 2018-02-07 | 2019-02-07 | A vaccine composition and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021512966A JP2021512966A (ja) | 2021-05-20 |
| JP2021512966A5 true JP2021512966A5 (enExample) | 2021-11-25 |
Family
ID=67547868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564972A Pending JP2021512966A (ja) | 2018-02-07 | 2019-02-07 | ワクチン組成物およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12311019B2 (enExample) |
| EP (1) | EP3749356A4 (enExample) |
| JP (1) | JP2021512966A (enExample) |
| CN (1) | CN112203681B (enExample) |
| AU (1) | AU2019216873B2 (enExample) |
| CA (1) | CA3090552A1 (enExample) |
| WO (1) | WO2019153042A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023026881A1 (ja) * | 2021-08-25 | 2023-03-02 | 東亞合成株式会社 | 抗ｐｄ－１シグナルペプチド抗体とその利用 |
| KR102401860B1 (ko) * | 2021-10-21 | 2022-05-24 | 을지대학교 산학협력단 | 신규 항암 백신 조성물 및 그를 이용한 백신화 방법 |
| KR102421307B1 (ko) * | 2021-11-19 | 2022-07-14 | 을지대학교 산학협력단 | 암 발생 및 성장 억제를 위한 신규 항암 백신 조성물 및 그를 이용한 백신화 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR056591A1 (es) * | 2005-10-28 | 2007-10-10 | Vaxinnate Corp | Polipeptidos ligandos para receptor 4 simil toll (tlr4) |
| US20120082687A1 (en) * | 2010-10-04 | 2012-04-05 | Alex Wah Hin Yeung | Use of cell adhesion inhibitor for the mobilization of antigen presenting cells and immune cells in a cell mixture (AIM) from the peripheral blood and methods of use |
| KR102181258B1 (ko) * | 2012-02-16 | 2020-11-20 | 브이엘피 테라퓨틱스 엘엘씨 | 바이러스 유사 입자 조성물 |
| PL3489254T3 (pl) | 2012-04-30 | 2023-01-30 | Biocon Limited | Ukierunkowujące/immunomodulujące białko fuzyjne i sposoby jego otrzymywania |
| WO2014161509A1 (en) * | 2013-04-05 | 2014-10-09 | The University Of Hong Kong | Novel pd1 isoforms, and uses thereof for potentiating immune responses |
| TWI676636B (zh) * | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| US9969986B2 (en) * | 2014-08-08 | 2018-05-15 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| DK3237446T3 (en) * | 2014-12-22 | 2021-07-26 | Pd 1 Acquisition Group Llc | Anti-PD-1-antistoffer |
| RU2726411C2 (ru) * | 2015-04-17 | 2020-07-14 | Биолайф Сайенс Клд Лимитед | Вакцинная композиция и ее применения |
| WO2016183469A1 (en) * | 2015-05-13 | 2016-11-17 | Robert Kirken | Anti-ctla-4 blockade |
| AU2016317915B2 (en) * | 2015-09-01 | 2021-02-18 | Agenus Inc. | Anti-PD-1 antibodies and methods of use thereof |
| ES2963635T3 (es) * | 2017-03-28 | 2024-04-01 | Ohio State Innovation Foundation | Vacunas de péptido PD1 humano y usos de las mismas |
-
2019
- 2019-02-07 WO PCT/AU2019/050089 patent/WO2019153042A1/en not_active Ceased
- 2019-02-07 JP JP2020564972A patent/JP2021512966A/ja active Pending
- 2019-02-07 CA CA3090552A patent/CA3090552A1/en active Pending
- 2019-02-07 US US16/966,442 patent/US12311019B2/en active Active
- 2019-02-07 EP EP19751452.4A patent/EP3749356A4/en active Pending
- 2019-02-07 AU AU2019216873A patent/AU2019216873B2/en active Active
- 2019-02-07 CN CN201980024131.4A patent/CN112203681B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7820180B2 (en) | Listeria-based and LLO-based vaccines | |
| TWI232753B (en) | Adjuvant compositions comprising QS-21,3D-MPL and CpG and vaccine compositions comprising the same | |
| US7662396B2 (en) | Compositions and methods for enhancing the immunogenicity of antigens | |
| Ellis | New technologies for making vaccines | |
| JP5597197B2 (ja) | 非溶血性ｌｌｏ融合タンパク質およびそれを利用する方法 | |
| AU2002244337B2 (en) | Vaccines | |
| US20080124354A1 (en) | Methods for administering tumor vaccines | |
| JP2007508272A (ja) | インターロイキン１８およびサポニンアジュバント系を含むワクチン組成物 | |
| US8895017B2 (en) | HER-2 peptides and vaccines | |
| JP2021512966A5 (enExample) | ||
| JP5307859B2 (ja) | ワクチン | |
| AU2005232396B2 (en) | Vaccination against malignant melanoma using BCG and/or vaccinia | |
| JP2008285487A (ja) | ワクチン | |
| Lenarczyk et al. | ISCOM® based vaccines for cancer immunotherapy | |
| CN111295200B (zh) | 作为疫苗中的佐剂的包含合成的神经节苷脂gm3变体的纳米颗粒 | |
| JP6385280B2 (ja) | 自家癌細胞ワクチン | |
| TWI740823B (zh) | 疫苗組成物及其用途 | |
| WO2009127666A2 (en) | Method and compositions | |
| Loosmore et al. | Protein-Based Vaccines | |
| Karyampudi et al. | Effectiveness of Idiotype-Adjuvant Conjugate Vaccine Against a B-Cell Lymphoma | |
| Ramakrishna et al. | EGFRvIII Vaccine-specific Induction of Humoral and Cell-Mediated Immunity | |
| MXPA06003861A (es) | Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina |